S00–T88: Injury, Poisoning and Certain Other Consequences of External Causes
Injury, Poisoning and Certain Other Consequences of External Causes diagnostic classification updated for 2026.
- T45.95XD|
Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
- T45.96XD|
Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter
- T45.A|
Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs
- T45.AX|
Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs
- T45.AX1|
Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional)
- T45.AX1A|
Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), initial encounter
- T45.AX1D|
Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), subsequent encounter
- T45.AX1S|
Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), sequela
- T45.AX2A|
Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, initial encounter
- T45.AX2D|
Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, subsequent encounter
- T45.AX2S|
Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, sequela
- T45.AX3A|
Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, initial encounter
- T45.AX3D|
Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, subsequent encounter
- T45.AX4A|
Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, initial encounter
- T45.AX4D|
Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, subsequent encounter
- T45.AX5A|
Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounter
- T45.AX5D|
Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter
- T45.AX6D|
Underdosing of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter
- T46|
Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system
- T46.0|
Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
- T46.0X|
Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
- T46.0X1|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional)
- T46.0X1A|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
- T46.0X1D|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter
- T46.0X1S|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela
- T46.0X2|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm
- T46.0X2A|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
- T46.0X2D|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter
- T46.0X2S|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela
- T46.0X3A|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
- T46.0X3D|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter
- T46.0X4A|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
- T46.0X4D|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter
